Austen Watkins, DO
Physical Medicine & Rehabilitation · Fort Worth, TXNPI 1407113053
Payments from drug & device makers
Across 126 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Merz Pharmaceuticals, LLC$467
- Merz North America, Inc.$202
- Medtronic$191
- Ipsen Biopharmaceuticals, Inc$130
- Piramal Critical Care$121
- plus $332 from 11 others
What the payments were for
- Food & beverage$2,725100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $1,281 |
| Merz Pharmaceuticals, LLC | 13 | $467 |
| Merz North America, Inc. | 7 | $202 |
| Medtronic(2 entities) | 9 | $191 |
| Ipsen Biopharmaceuticals, Inc | 7 | $130 |
| Piramal Critical Care | 7 | $121 |
| Avanir Pharmaceuticals, Inc. | 4 | $78 |
| Amneal Pharmaceuticals LLC | 3 | $48 |
| Nevro Corp. | 1 | $44 |
| Microtransponder, Inc. | 2 | $39 |
| Si-bone, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Neuros Medical, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Ossur Americas, Inc. | 1 | $16 |
How this compares
$2,725 in reported general payments places this provider in the 85th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 12 | $332 |
| Lidocaine | 19 | $300 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Fort Worth
- Benecia WilliamsFort Worth$5K
- Omar SelodFort Worth$5K
- Lan leFort Worth$5K
- Christine VidouriaSan Antonio$841K
- Fatma GulDallas$573K
- Gerard FranciscoHouston$520K
- Jose UrquidezAustin$332K
- Cindy IvanhoeHouston$267K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.